News
Asuri Launches Multi-Agent AI Platform for Enterprise Workflows
Asuri has launched a multi-agent enterprise AI platform designed to automate business processes across existing software systems. The platform lets nontechnical teams configure workflows, assign specialized AI agents to different tasks, connect business applications and set permissions governing what agents can access or execute. With more than 1,000 integrations, Asuri is positioning its product as…
Anrok Launches MCP Connection for AI-Powered Tax Workflows
Anrok has launched Anrok MCP, a Model Context Protocol (MCP) connection that lets AI assistants access tax data and perform selected operations within the company’s global tax infrastructure platform. The integration supports Claude, ChatGPT, Cursor and VS Code, allowing finance teams to query transactions, review filings, reconcile billing data and manage tax records through conversational…
SuperCom Launches SafeGenie to Secure Enterprise AI Agents
SuperCom has introduced SafeGenie, a cybersecurity product suite designed to monitor and control autonomous AI agents in real time. The product combines patent-pending agentic AI security methods with kernel-level endpoint security technology from Safend, SuperCom’s cybersecurity subsidiary. It is intended to help enterprises govern AI actions, prevent sensitive-data exposure and enforce security policies as AI…
Cognizant to Acquire DyFlex, Expanding AI-Led SAP Services
Cognizant has signed a definitive agreement to acquire DyFlex Solutions, an Australia-based SAP transformation firm, in a move designed to expand its enterprise AI and SAP capabilities across Australia and New Zealand. The proposed acquisition would combine DyFlex’s regional consulting expertise and proprietary delivery tools with Cognizant’s global services and AI platforms, targeting organizations modernizing…
PerturbAI and OpenAI Use AI Agents to Accelerate Drug Discovery
Biotechnology company PerturbAI and OpenAI have developed an AI reasoning framework designed to help scientists interpret complex biological experiments and identify potential drug discovery leads. Working with Scripps Research, the teams combined causal genomic data from living systems with multiple AI agents that analyze cellular responses, search scientific literature and connect experimental findings to possible…
Guest Column
